Alternative names
2-DPMP
Current Scheduling Status
N/A
Year(s) and type of review / ECDD meetings
Added to surveillance list by 2nd WG meeting (2017)
Drug Class
Recommendation (from TRS)
Information has been brought to WHO’s attention that 2-DPMP is being misused and has been identified in seized products in a number of Member States. 2-DPMP produces amphetamine-like effects that include euphoria, increased blood pressure and temperature, decreased appetite, increased wakefulness and physical activity, along with rapid and/or irregular heartbeat. 2-DPMP has been associated with fatal and non-fatal intoxications. To date, 2-DPMP has not been pre- or critically reviewed by the ECDD.